Neuromusculoskeletal Medicine & OMM · Fullerton, CA
NPI
1689831380
Since 2008
Specialty
Neuromusculoskeletal Medicine & OMM
Code 204D00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
381 E Imperial Highway
Fullerton, CA, 92835
Phone (714) 879-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
903 services
Medicare patients, 2024
375
Average age 77
Drug cost, 2024
$1.2M
3,565 prescriptions
Company payments, 2025
$1,279
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kiran K Bath was code 99214 (office e&m - established), 307 times for 191 patients. In total Kiran K Bath billed 903 services in 27 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 191 | $87.97 | $27K |
| 99215 Office E&M - Established | Office | 141 | 108 | $133.56 | $19K |
| 99213 Office E&M - Established | Office | 123 | 84 | $57.58 | $7,083 |
| 99204 Office E&M - New | Office | 48 | 48 | $114.83 | $5,512 |
| 99205 Office E&M - New | Office | 43 | 43 | $160.28 | $6,892 |
| 95886 Electrical Nerve Conductivity | Office | 35 | 20 | $75.77 | $2,652 |
| 95819 Neurologic | Office | 35 | 34 | $322.45 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 21 | $59.00 | $1,593 |
| 99233 Hospital E&M - Subsequent | Facility | 26 | 21 | $88.77 | $2,308 |
| 95816 Neurologic | Facility | 25 | 25 | $42.75 | $1,069 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $129.40 | $1,812 |
| 99291 Critical Care E&M | Facility | 14 | 13 | $157.65 | $2,207 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $97.75 | $1,173 |
| 95909 Electrical Nerve Conductivity | Office | 11 | 11 | $107.26 | $1,180 |
By year: 2022 $112K for 1,051 services; 2023 $121K for 1,065 services; 2024 $97K for 903 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kiran K Bath prescribed most often to Medicare patients was Donepezil Hcl, with 482 prescriptions and refills. In total Kiran K Bath wrote 3,565 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 482 | 1,190 | 164 | $4,815 |
| Memantine Hcl Generic | 203 | 470 | 65 | $13K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 202 | 471 | 58 | $7,062 |
| Gabapentin Generic | 183 | 396 | 64 | $3,546 |
| Sertraline Hcl Generic | 130 | 268 | 51 | $2,474 |
| Mirtazapine Generic | 124 | 232 | 41 | $2,134 |
| Quetiapine Fumarate Generic | 115 | 222 | 34 | $1,893 |
| Duloxetine Hcl Generic | 95 | 199 | 30 | $3,194 |
| Primidone Generic | 81 | 189 | 21 | $2,251 |
| Zonisamide Generic | 76 | 195 | 26 | $2,587 |
| Levetiracetam Generic | 74 | 181 | 22 | $3,038 |
| Escitalopram Oxalate Generic | 71 | 165 | 21 | $585 |
| Rivastigmine Rivastigmine Tartrate | 67 | 115 | 22 | $4,488 |
| Propranolol Hcl Generic | 65 | 138 | 27 | $697 |
| Memantine Hcl Er Memantine Hcl | 65 | 160 | 21 | $8,621 |
Brand drugs: - claims; generic drugs: 3,306 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kiran K Bath $1,279 ($1,279 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $279 |
| Abbott Laboratories ABT | 3 | $207 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $192 |
| Celgene Corporation BMY | 8 | $174 |
| Biogen, Inc. BIIB | 3 | $74.85 |
| CSL Behring CSL.AX | 2 | $71.41 |
| Merz Pharmaceuticals, LLC | 2 | $57.99 |
| UCB, Inc. UCB.BR | 3 | $53.56 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $26.38 |
| Pfizer Inc. PFE | 1 | $26.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.